Business
Launch of Abingdon Simply Test e-commerce website
Launch of Abingdon Simply Test e-commerce website.
About this update from Abingdon Health Plc
[{"type":"text","content":"\n \n \n \n Abingdon Health plc\n \n \n \n (\"Abingdon\" or \"the Company\")\n \n \n \n \n \n \n \n \n Launch of\n \n \n Abingdon Simply Test e-commerce website\n \n \n \n \n \n \n \n York, U.K. 21 July 2022:\n \n Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces the launch of its new B2C e-commerce website,\n \n abingdonsimplytest.com\n \n .\n \n \n \n The Abingdon Simply Test website will provide UK and international customers with Abingdon Simply Test and Abingdon-assured third-party branded self-tests. All products will be regulatory approved and manufactured under international quality management systems.\n \n \n \n \n \n The e-commerce site has launched with a range of tests in areas such as fertility, health and well-being and infectious disease. It is Abingdon's intention to broaden the range of available tests, with a focus on self-testing.\n \n \n \n \n \n The Abingdon Simply Test website will provide consumers with simple, jargon-free information to enable them to make considered purchasing decisions. All tests on the\n \n abingdonsimplytest.com\n \n site will also have undergone Abingdon's 10-point evaluation covering quality, regulatory and usability requirements to provide customers with greater assurance on the quality of these tests.\n \n \n \n Self-testing is a major growth area within the global diagnostic market and\n in its recent report, Future Market Insights forecast the global market for self-testing kits will be worth US $11bn by 20301.\n Lateral flow testing has seen a significant increase in profile and familiarity following the rapid expansion of COVID-19 lateral flow self-testing during the pandemic. The increased awareness amongst the general public of lateral flow testing coupled with its benefits such as low cost and ease-of-use means that LFT testing will play a major role in the democratisation of testing and the empowerment of individuals to manage their own health.\n \n \n \n \n Chris Yates, CEO of Abingdon Health plc, commented:\n \n \n \"The healthcare landscape is changing and the increase in lateral flow testing during the COVID-19 pandemic has served as a catalyst for a paradigm shift in moving diagnostic testing out of the laboratory and into the home. Consumer...